Richard Aplenc

Assistant Vice President and Chief Clinical Research Officer

Dr. Aplenc investigates ways to improve the outcomes of children with cancer, particularly acute myeloid leukemia, with clinical epidemiology studies and translational research.

19:30 - 19:55 PM

20 May 2022 Day 1: Friday

An Update on treatment of newly diagnosed AML